- Assistant Professor of Sociology at the University of Miami
- Pro to the question "Should Prescription Drugs Be Advertised Directly to Consumers?"
“Prescription drug advertisements spread valuable educational information about the promoted product and conditions associated with the drug. Better-educated patients can make well-informed decisions regarding their own health care…
DTCA [direct-to-consumer advertisements] can motivate patients to bring to physicians’ attention the information they receive about diseases and products in advertisements… Constraints on physicians’ time make it vital for patients to be educated outside of the physician’s office so that they can use the time with their physicians as effectively as possible… DTCA also motivates patients to disclose difficult to discuss issues, particularly for highly stigmatized diseases such as depression and attention-deficit/hyperactivity disorder.
The positive effects of DTCA on patients are grounded in evidence. These effects include greater involvement in medical decision-making, increased compliance with prescription medication intake, and improved patient-physician communication, which may lead to the diagnosis of previously undiagnosed medical conditions.”
“Direct-to-Consumer Advertising of Prescription Drugs Can Inform the Public and Improve Health,” Journal of the American Medical Association (JAMA) Oncology, Nov. 2016
- Involvement and Affiliations:
- Assistant Professor, Muhlenberg College, July 2018-present
- Assistant Professor of Sociology, University of Miami, 2013-present
- Adjunct Professor, Department of Sociology, Furman University, 2011-2012
- Teaching Assistant, Brown University, 2008-2009
- MPH, Health Policy and Management, Harvard School of Public Health, 2013
- PhD, Sociology, Brown University, 2012
- MA, Sociology, Texas Tech University, 2006
- BS, Sociology, Texas A&M University, 2003
- None found
- Quoted in:
- Pro & Con Quotes: Should Prescription Drugs Be Advertised Directly to Consumers?